Form 483

Auro PR Inc. Form 483, 2018-03-15

FDA issued a Form 483 to Auro PR Inc. on 2018-03-15 with 4 public-safe observations.

483· Form 483 issuedHuman Drugs4 observations

Auro PR Inc. · Caguas, United States · Issued March 15, 2018

Overview

  • 4 public-safe observations are available for this inspection.
  • 4 structured CFR citations are represented.
  • 4 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

15 Mar 2018
21 CFR 211.160(b)(4)

Calibration - at intervals, written program, remedial action

Cited by Vilmary Negron Rodriguez, Jose A Lopez Rubet, Marian E Ramirez, Jose R Flores-Veguilla

15 Mar 2018
21 CFR 211.67(a)

Cleaning / Sanitizing / Maintenance

Cited by Vilmary Negron Rodriguez, Jose A Lopez Rubet, Marian E Ramirez, Jose R Flores-Veguilla

15 Mar 2018
21 CFR 211.67(b)(3)

Cleaning SOPs/instructions

Cited by Vilmary Negron Rodriguez, Jose A Lopez Rubet, Marian E Ramirez, Jose R Flores-Veguilla

15 Mar 2018
21 CFR 211.82(a)

Examination on receipt, before acceptance

Cited by Vilmary Negron Rodriguez, Jose A Lopez Rubet, Marian E Ramirez, Jose R Flores-Veguilla

Inspected site

APAuro PR Inc.Caguas, United States

Inspection team

VNVilmary Negron Rodriguez
JAJose A Lopez Rubet

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.160(b)(4)Cited across public-safe Form 483 observations1x
21 CFR 211.67(a)Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)(3)Cited across public-safe Form 483 observations1x
21 CFR 211.82(a)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 4 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere